Co-creating New Value for Life Sciences Companies
WNS partners with marquee life sciences companies, including 12 of the world’s top 20 brands, to co-create solutions powered by the trifecta – domain expertise, analytics and digital technology. We enable companies to find sustainable value in a landscape marked by diminishing Research and Development (R&D) returns, increasing costs, rising pricing pressures, growing regulatory demands and accelerated influence of the non-medical ecosystem.
We collaborate with global clients to drive faster commercial success with our comprehensive portfolio of research and analytics solutions, including cloud, and Artificial Intelligence (AI)- and Machine Learning (ML)-led products and platforms. We also leverage our innovative automation and analytics solutions to transform finance and procurement operations. The key outcomes we help achieve include commercial effectiveness, reduced costs, faster time-to-market, increased revenues and greater market access.
With the COVID-19 pandemic disrupting operations, and R&D efforts of pharma and medical devices companies, WNS has been working closely with the clients to drive business recovery and help them adapt to the new normal.